Ayala Pharma

Developer of small molecule-based therapeutics for cancer treatment

placeWilmington, Delaware, United States calendar_todayFounded 2017 groups21 employees language ayalapharma.com

Registered entities

Investor mix

11 investors on record; lead investors include Novartis, Bristol-Myers Squibb.

Investor typeCountShare
Venture capital545%
Private equity19%
Other / undisclosed545%
Coming soon